Building the Factories of 2050, Today.
Electron Bio eliminates the biomanufacturing bottleneck. We deploy capital-efficient, modular infrastructure orchestrated by an intelligent AI overlay to accelerate advanced therapies to the clinic in months—not years.
Proud Members & Collaborators:
A New Paradigm for Genetic Medicine.
The traditional CDMO model was built for blockbuster drugs, not the era of personalized medicine. Electron Bio introduces a distributed, intelligent network. By decentralizing hardware and centralizing intelligence, we transform fixed capital burdens into operational velocity.
Operational Velocity: From shell space to operational readiness in under a year.
Capital Efficiency: 50-80% CapEx reduction. Turn fixed infrastructure costs into immediate clinical momentum.
Modality-Agnostic Agility: Standardized pods seamlessly pivot between mRNA, LNPs, ASOs, and Cell Therapies without altering facility architecture.